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Abstract. We performed subtractive and differential 
hybridization for transcript comparison between mu- 
rine fibroblasts and isogenic epithelium, and observed 
only a few novel intracellular genes which were rela- 
tively specific for fibroblasts. One such gene encodes a 
filament-associated, calcium-binding protein, fibro- 
blast-specific protein 1 (FSP1). The promoter/enhancer 
region driving this gene is active in fibroblasts but not 
in epithelium, mesangial cells or embryonic endoderm. 
During development, FSP1 is first detected by in situ 
hybridization after day 8.5 as a postgastrulation event, 
and is associated with cells of mesenchymal origin or of 
fibroblastic phenotype. Polyclonal antiserum raised to 
recombinant FSP1 protein stained the cytoplasm of fi- 
broblasts, but not epithelium. Only occasional cells 
stain with specific anti-FSP1 antibodies in normal pa- 
renchymal tissue. However, in kidneys fibrosing from 
persistent inflammation, many fibroblasts could be 
identified in interstitial sites of collagen deposition and 
also in tubular epithelium adjacent to the inflammatory 
process. This pattern of anti-FSP1 staining during tissue 
fibrosis suggests, as a hypothesis, that fibroblasts in 
some cases arise, as needed, from the local conversion 
of epithelium. Consistent with this notion that FSP1 
may be involved in the transition from epithelium to fi- 
broblasts are experiments in which the in vitro overex- 
pression of FSP1 cDNA in tubular epithelium is accom- 
panied by conversion to a mesenchymal phenotype, as 
characterized by a more stellate and elongated fibro- 
blast-like appearance, a reduction in cytokeratin, and 
new expression of vimentin. Similarly, tubular epithe- 
lium submerged in type I collagen gels exhibited the 
conversion to a fibroblast phenotype which includes de 
novo expression of FSP1 and vimentin. Use of the FSP1 
marker, therefore, should further facilitate both the in 
vivo studies of fibrogenesis and the mapping of cell fate 
among fibroblasts. 
F 
IBROBLASTS are traditionally  viewed as pedestrian 
interstitial cells normally responsible for tissue in- 
frastructure and organ remodeling. Fibroblasts syn- 
thesize an extracellular matrix comprising collagen types I 
and III, fibronectin and proteoglycans (10, 27, 40). Over- 
production  of these  moieties  during  fibrogenesis,  after 
chronic inflammation or injury, leads to excessive collagen 
deposition in parenchymal tissues that eventually acceler- 
ates organ insufficiency (24, 45). 
Recent evidence also suggests that fibroblasts acquire a 
functional  heterogeneity  from the  microenvironment  in 
which they develop (5, 65). Cultured fibroblasts, for exam- 
ple,  synthesize  different  types of collagen  according  to 
their site of origin (9) and respond differently to fibrogenic 
cytokines (5). Fibroblasts are easy to culture (9) and hence 
have been well characterized in vitro. However, the basis 
for their origin,  heterogeneity, and  abundance during in 
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vivo fibrogenesis has not been well studied because of a 
lack of good markers. Studies on the formation of intersti- 
tial fibrosis in organs such as lung (13),  liver (57),  heart 
(76), or kidney (54) have had to rely on the often impre- 
cise technique of in situ hybridization using probes recog- 
nizing interstitial collagens. 
Here we describe the isolation of several fibroblast-spe- 
cific genes by comparative transcript analysis. We find that 
one gene, FSP1, is highly specific for fibroblasts and is as- 
sociated with the conversion of epithelial cells to a fibro- 
blast phenotype. 
Materials and Methods 
Cell Culture 
Murine cell lines were all previously established and grown at recom- 
mended conditions: renal tubulointerstitial fibroblasts (TFB) 1 and dermal 
1. Abbreviations used in this paper, DFB, dermal fibroblasts; ES, embry- 
onic stem cells; FSP1, fibroblast-specific  protein 1; MCT, murine proximal 
tubular epithelial cells; MMC, mesangial cells; TFB, tubulointerstitial fi- 
broblasts. 
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thelial cells  (MCT)  (34), murine distal tubular cells  (NP-1)  (gift of Dr. 
Fuad Ziyadeh, University of Pennsylvania, PA), mesangial cells (MMC) 
(78), M30 T cells (53), BAL-17 B cells (3), microvascular endothelial cells 
(60) (a generous gift of Dr. Auerbach, University of Wisconsin), hepato- 
cytes (67), pancreatic islets (28), osteoblasts (OB) and thymic fibroblasts 
(ThyFB)  (gift of Dr. Barbara Knowles, Jackson Laboratories,  Bar Har- 
bor, ME), F9 teratocarcinoma cells (73) and PYS-2 (47), and embryonic 
stem cells (ES) (11). In some experiments, NP-1 epithelium were grown as 
cultures submerged in collagen type I  (Collaborative Research, Bedford, 
MA) using previously established methods (31). 
Comparative Transcript Analysis 
A  eDNA library was prepared using transcripts from TFB fibroblasts (5), 
packaged in Larnbda Zap II  TM (Stratagene, La Jolla, CA), and plated on 
E. coli strain SURE for screening. A total of lg0,000 clones were screened 
by double lift differential hybridization using [~2P]cDNA  probes prepared 
from 5 i~g of poly(A) + RNA isolated from TFB fibroblasts or MC'F epithe- 
lium and primed with oligo(dT)lz_ls/random primers in the presence of re- 
verse transcriptase (6). Typically, 2  ×  105 cpm/ml of probe were used per 
filter. Approximately 1.65  ×  106 clones from the TFB eDNA library were 
also screened with a subtracted probe (69) using mRNA from MCT epithe- 
lium according to protocol for the Subtractor I  TM kit (Invitrogen, San Di- 
ego, CA). All clones obtained at final purity were independently isolated 
at least two times. Inserts were sequenced  by chain termination (3) and 
subsequently used as probes on Northern blots using total cellular or organ 
RNA, as well as poly A + mRNA (3). Up to 30 p.g of RNA were loaded 
onto  a  1.3%  RNase-free  agarose gel in 2.2 M  formaldehyde  and trans- 
ferred to Genescreen  TM membrane (New England Nuclear, Boston, MA) 
in 10  ×  SSC buffer. All eDNA probes  (2  ×  105 cpm/ml), including the 
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
were labeled with random primers (3). Hybridizations were performed at 
high stringency in 0.1 ×  SSC at 65°C (34). 
Assembly of Shuttle Vectors 
A  genomic clone (7cG), encoding FSP1, was isolated from an NIH/3T3 
genomic library in h FIX II (Stratagene). An EcoR1 fragment (containing 
~2,500 bp 5' to the transcription start site, the first two introns and the 
first two and parts of the third exon) was subcloned into pBSKSII (Strata- 
gene) and subjected to further restriction analysis and partial sequencing. 
A  luciferase reporter construct (pBK18001uc) was assembled by ligating 
the BglII (ca.-i,800 bp) and NheI  (+65  bp) ganomic fragment into the 
BamHI and KpnI sites of pXP-2 (59). This places the luciferase gene un- 
der the control of the 5' flanking region of the FSP1 gene. Transient trans- 
fections were carried out using CaPO4  (3).  10 t~g of plasmid DNA was 
cotransfected with 2 txg of pCHll0 (Pharmacia LKB Biotechnology, Pis- 
cataway,  NJ), a  vector expressing [3-galactosidase, into 5-10  ×  105 cells 
plated on 60-mm dishes, pSV21uc containing the SV40-promoter/enhancer 
served as a positive control (59). Medium was changed 24 h later and cells 
were harvested 48 h after transfection by lysis in KPO4-DTr with 1% Tri- 
ton X-100. Supernatants were assayed for luciferase activity in a  Lumat 
LB 9501  luminometer.  13-Galactosidase activity was measured  (63), and 
luciferase activity was normahzed accordingly, eDNA encoding FSP1 con- 
taining the ATG start codon was also cloned into pcDNA-Neo  (Invitro- 
gen) for transfection into MCT cells. 24 h  after transfection, cells were 
subjected to selective medium (DMEM +  700 mg/ml Geneticin  TM) for 14 d 
and then subcloned by limiting dilution. MCT cells stably transfected with 
pcDNA-Neo  alone served as negative control. FSP1 expression was veri- 
fied in selected clones by Northern analysis (15, 27). 
Expression and Purification of Recombinant FSP1 
The  coding  region  of  FSP1  (p48b1)  was  amplified  with  5'-BamHFin- 
frame and 3'-HindlII/termination primers and Taq polymerase in a stan- 
dard cycler protocol (3). The 5'-primer contained an additional sequence 
coding for the tetrapeptide Ile-Glu-Gly-Arg, as a specific cleavage site for 
the blood coagulation factor X a (56). The amplification product was sub- 
cloned into the TA cloning vector pCRT~II (Invitrogen) for sequencing. 
Double cuts with BamHI and HindlII produced a forced in-frame ligation 
into pDS-MCS (gift of Dr. Tom Genetta, Howard Hughes Medical Insti- 
tute at the University of Pennsylvania) for protein expression in MC 1061 
E. coli containing helper plasmid pDMI-1  (58). The expressed FSP1 fu- 
sion protein contains 6 tandem histidine residues in the fusion sequence 
that allowed for affinity purification over a nickel resin column employing 
a step gradient elution with 25-200 mM imidazole into 8 M urea using pro- 
tocols available from Quiagen  (Chatsworth,  CA). The purity of the ex- 
pressed protein was determined  on an 18%  SDS-PAGE  gel using Coo- 
massie blue staining. Polyclonal antiserum against purified recombinant 
FSP1 was generated in a New Zealand white rabbit. 
Immunoblot Analysis 
One-dimensional immunoblots were performed  using lysates from 3T3, 
TFB, and MCT cells obtained by lysis with a detergent based buffer (66). 
100 Izg of total cellular protein and 1 Ixg FSPl-fusion protein were run on 
an  18%  SDS-PAGE  gel  and  transferred  to  a  nitrocellulose  membrane 
(Schleicher &  Schuell,  Keene,  NH)  by electroblotting.  1  Ixg of murine 
RANTES-fusion protein containing an identical leader sequence was used 
as a negative control. To control for equally loaded amounts and adequate 
transfer, the membrane was stained with panceau red. After blocking with 
blotto/tween  solution,  the  membrane  was  incubated  with  the  primary 
polyclonal antibody in a 1:10,000  dilution followed by the secondary anti- 
body (donkey-anti-rabbit, horseradish peroxidase linked; Amersham, Ar- 
lington Heights, IL). Positive reaction products were identified by chemi- 
luminescence  (ECL,  Amersham)  according  to protocols  available from 
the manufacturer. 
Immunohistocytochemistry 
Cells were grown on gelatin-coated coverslips or glass slides for 24 h, fixed 
Figure  1.  Northern  analysis 
of FSP1.  The  transcript  size 
for  FSP1  was  0.65  kb.  (A) 
MCT  epithelium,  TFB  fibro- 
blasts,  BAL  B-lymphocytes, 
M30  T-lymphocytes,  MMC 
mesangial cells. (B) MCT ep- 
ithelium, TFB and 3T3 fibro- 
blasts, ADI  adipocytes,  END 
endothelial  cells,  HEP  hepa- 
tocytes,  PI  pancreatic  islet 
cells,  OB  osteoblasts,  and 
ThyFB  thymic  fibroblasts. 
(C)  MCT  epithelium,  3T3  fi- 
broblasts,  ES  embryonic 
stem cells, and F9 and PYS-2 
cells.  (D)  MCT-epithelium, 
TFB-,  3T3-,  and  dermal  fi- 
broblasts  (DFB).  (E)  RNA 
from whole organs. 
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antibodies in dilutions of 1:50-1,000; rabbit anti-FSP1; rabbit anti-vimen- 
tin, and rat anti-cytokeratin. After several washes in PBS, cells were incu- 
bated with optimal concentrations of secondary antibody FITC-goat anti- 
rabbit IgG (F(ab')z-fragment) or FITC-rabbit anti-rat IgG (F(ab')2-frag- 
ment)  (35). Normal organs from 6--8 wk SJL/J mice were fixed in 1% 
paraformaldehyde and embedded in paraffin, Sections of 4-45 ~.m were cut 
and mounted on microscope slides. Before antibody incubation, the paraf- 
fin sections were deparaffinized in xylene and ethanol, rehydrated, and di- 
gested with proteinase K (6 ~g/ml) for 20 rain at room temperature (39). 
The polyclonal anti-FSP1 antibody was used in a concentration of 1:50-1: 
200. The preimmunization sera served as negative control. Positive reac- 
tion products were identified using the DAKO PAP KIT  TM according to 
protocols available from the manufacturer (Dako, Carpinteria, CA). Sec- 
tions were counterstained  with Harris's  hematoxylin. Kidneys demon- 
strating  interstitial  inflammation were  also  harvested  and  stained  as 
above. Sections from all kidneys underwent trichrome staining to localize 
collagen. 
In Situ Hybridizations 
In situ hybridizations were performed on 8.5, 12.5, and 13.5-d-old  mouse 
embryos that were fixed in modified Carnoy's fixative and embedded in 
paraffin  (35). FSP1 sense/antisense riboprobes  were synthesized by in 
vitro transcription of FSPI-cDNA in pBS SK- in the presence of [35S]rUTP 
(800 mCi/mmol; Amersham). Each slide was hybridized with 5 × 106 cpm 
of probe in 100 p,1 of solution containing 50% formamide/10% dextran 
sulfate/0.3 M NaC1/10 mM Tris, pH 7.5/10 mM sodium phosphate/5 mM 
EDTA/10 mM dithiothreitol/1 × Denhardt's/10 mM thio-dATP/l.5 ixg/ml 
yeast tRNA at 55°C overnight (19). The slides were then treated with 
RNase, washed, dipped in Kodak NTB2 emulsion, and developed after 21 d 
of exposure using Kodak Dektol developer. The slides were then stained 
with toluidine blue and mounted with Permount  TM resin. 
Results 
Assessment of Unique Fibroblast Transcripts by 
Comparative Hybridization 
To identify new markers in fibroblasts, we screened TFB 
fibroblast cDNA by differential and subtractive hybridiza- 
tion with isogenic transcripts from MCT epithelium. In the 
first series of experiments, 180,000 plaques were screened 
by differential hybridization yielding four differentially ex- 
pressed clones: the etl- and the o2- chains of collagen type 
I, osteopontin, and a  fourth clone which demonstrated by 
Northern analysis the highest fibroblast specificity and was 
subsequently  named  fibroblast-specific  protein  (FSP1). 
All four clones were obtained in several isolations. North- 
ern hybridization of these four clones registered signals of 
4.7 and 5.7 kb for ~1(I) collagen, 5.3 kb for a2(I) collagen, 
1.5 kb for osteopontin, and 0.65 kb for FSP1. The cDNAs 
for the two collagen chains were partially sequenced and 
showed identity to the published genes (23, 62) and were 
not characterized further. The cDNA for osteopontin was 
sequenced in its entire length (1,372 bp) and proved to be 
identical to the published murine gene (55). Northern blot 
analysis revealed a high level expression of osteopontin in 
tubulointerstitial (TFB)  and  3T3  fibroblasts, and  adipo- 
cytes,  and  low  level  expression  in  tubular  epithelium 
(MCT)  and hepatocytes, osteoblasts, thymic (ThyFB)  fi- 
broblasts, embryonic  (ES)  stem  cells, and F9 cells (data 
not shown). There was no expression detectable in endo- 
thelial cells, pancreatic islets, B  and T  cells, PYS-2 cells or 
dermal  (DFB)  fibroblasts.  Thus,  the  expression  of  os- 
teopontin confirms the phenotypic distinctions between fi- 
broblasts of different origin, but is not highly specific. 
The fourth clone, FSP1, was detected in high abundance 
on Northern blots in all fibroblast cells examined, includ- 
ing TFB and 3T3, ThyFB, and DFB fibroblasts (Fig. 1 D), 
with a  transcript size of ~0.65 kb. There were little or no 
transcripts encoding FSP1 in all nonfibroblast cells exam- 
ined, including proximal tubular  cells (MCT),  mesangial 
cells (MMC), B  and T  lymphocytes, adipocytes, endothe- 
lial  cells,  hepatocytes,  pancreatic  islets,  and  osteoblasts 
(Fig. 1, A  and B). Furthermore, no transcripts were detect- 
able in ES, F9, and PYS-2 cells of early embryonic origin 
(Fig. 1 C). In RNA isolated from whole organs, transcripts 
encoding FSP1  were  readily detectable  in  lung,  kidney, 
and spleen (Fig. 1 E), weakly present in muscle and heart, 
Figure 2.  Expression of FSP1 
as a fusion protein. (A) Immu- 
noblot  with  the  polyclonal 
anti-FSP1 antibody. Recombi- 
nant RANTES fusion protein 
(rRAN) served as negative, re- 
combinant  and FSP1  (rFSP1) 
as positive control. Protein ex- 
tracts from TFB and 3T3 fibro- 
blasts  are  positive  for  FSP1, 
while MCT epithelium is not. 
The  main  band  in  the  rFSP1 
lane has  a  slightly larger size 
due  to  the  fusion  leader  se- 
quence. (B) TFB cells with the 
polyclonal anti-FSP1 antibody 
demonstrate strong staining in 
the cytoplasm of the fibroblast. 
(C)  Immunostaining  of MCT 
epithelium with anti-FSP1 an- 
tibody is negative. 
Strutz et al. Expression of  FSP1 in Fibroblasts  395 The Journal of Cell Biology, Volume 130, 1995  396 Figure 3.  Immunohistology with the polyclonal anti-FSP1 antibody in normal tissues  and fibrotic kidney. Staining of normal tissues 
demonstrate rare, occasional fibroblasts (marked with arrows) in kidney (A) and lung (B) interstitium, and in splenic pulp (C). Immu- 
nostaining with the polyclonal anti-FSP1 antibody in kidneys with fibrosis from anti-TBM disease at 8 wk (D) and 13 wk (F and G) after 
induction. In D there are occasional tubular conversions as well as new perivascular fibroblasts (see arrows). E illustrates  collagen de- 
position by trichrome staining in the same kidney as D. F  demonstrates progressive kidney involvement from anti-TBM disease at 
higher magnification; there are many tubules undergoing fibroblast conversion with new expression of FSP1 (see arrowheads). In G 
from the same kidney there are peri-glomerular tubules  (single arrowhead) and new adjacent peritubular  cells which have become 
FSP1 ÷ (double arrowheads). The adjacent glomerulus, while surrounded by early fibrogenesis, has not as yet undergone any phenotypic 
conversion. 
and not detectable  in liver  and brain; findings supported 
by immunochemistry in selected tissues  (infra vide). The 
cDNA encoding FSP1  was 480 bp in  length  and was se- 
quenced  in  its  entirety.  A  search  of the  NCBI database 
showed that  the  sequence  was identical  to pEL-98 (30), 
18A2 (42), and mtsl (20) of the S-100 superfamily. 
We next performed subtractive hybridization to look for 
rare transcripts missed by differential screening. This search 
yielded only one additional new clone, $44al. However, of 
all clones found, it was not as stringently specific for fibro- 
blasts as FSP1 (data not shown). 
Antiserum Against FSP1 Detects Fibroblasts In Vitro 
and In Vivo 
To further characterize fibroblasts in vivo, we generated a 
Figure 4.  FSP1  promoter is  active only 
in  fibroblasts.  (A)  Luciferase  reporter 
construct pBSK1800Luc for the analysis 
of the promoter activity of the 5' flank- 
ing region of the FSP1 gene. (B) Results 
of transient transfection in DFB and 3T3 
fibroblasts,  MCT  epithelium  PYS  cells 
and  MMC  mesangial  cells  reveals  the 
FSP1  promoter is  only active  in fibro- 
blasts. 
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fusion  protein.  The  studies  presented  here  were  per- 
formed  with  the  polyclonal antibody.  This  antibody  re- 
acted specifically with the FSP1 fusion protein on immu- 
Figure 5.  Overexpression of 
FSP1 cDNA in MCT.pFSP1.8 
tubular  epithelium  converts 
these  cells  towards  a  fibro- 
blast appearance. All plating 
densities  were  identical  at 
the beginning of culture pas- 
sage. (A) MCT.pFSP1.8 epi- 
thelium  stably  transfected 
with FSP1 do not form cuboi- 
dal sheets 72 h  after passage 
in subconfluent cultures, but 
rather maintain a  more stel- 
late or fibroblast appearance 
by  light  microscopy.  (B) 
MCT.pNeo epithelium stably 
transfected with the neomy- 
cin-resistance gene maintains 
a  capacity to  form  cuboidal 
sheets in focal sites after sub- 
confluent culture as early as 
48 h. (C) Using immunofluo- 
rescence, MCT.pFSP1.8 epi- 
thelium  express  cytoplasmic 
FSP1.  (D)  MCT.pNeo  epi- 
thelium  stably  transfected 
with the neomycin-resistance 
gene  do  not  express  FSP1. 
(E)  MCT.pFSP1.8  epithe- 
lium  now  express  vimentin. 
(F)  MCT.pNeo  epithelium 
do not express vimentin. (G) 
MCT.pNeo  epithelium  now 
express less cytokeratin. (H) 
MCT.pNeo  epithelium  con- 
tinue to express cytokeratin. 
noblots (Fig. 2 A) and was very specific for fibroblasts in 
cell culture (Fig. 2  B). On tissue sections of the kidney, it 
stained occasional interstitial cells (Fig. 3 A). Similar re- 
suits were obtained in the lung and spleen tissues (Fig. 3, B 
The Journal  of Cell  Biology,  Volume 130, 1995  398 Figure 6.  Cultures of NP-1 tubular epithelium submerged in collagen type I gels converts these cells to a fibroblast appearance. NP-1 
cells grown in submersion gels or controls grown on the surface of collagen-coated plates were analyzed at 72 h by immunofluorescence. 
(A) NP-1 control cells grown on the surface did not express FSP1. (B) NP-1 epithelium grown in submersion gels began to express FSPI. 
(C) NP-1 control cells grown on the surface did not express vimentin. (D) NP-1 epithelium grown in submersion gels began to express 
vimentin. (E) NP-1 control cells grown on the surface continue to express cytokeratin. (F) NP-1 epithelium grown in submersion gels in 
focal areas began expressing less cytokeratin as they undergo phenotypic conversion; converted cells in the dark center are particularly 
devoid of cytokeratin. 
and C, respectively). However, no staining was detectable 
on tissue sections of heart and liver (data not shown), a re- 
sult in concordance with the Northerns in Fig. 1 E, indicat- 
ing that most cells in these organs do not normally express 
FSP1. 
We next examined the staining pattern of fibroblasts in 
a mouse model of renal interstitial fibrosis (34). 8 wk after 
the  induction  of  interstitial  inflammation,  a  robust  in- 
crease in staining of the FSPl-reaction product was detect- 
able (Fig. 3 D). This was accompanied by increased inter- 
stitial collagen deposition as demonstrated by trichrome 
staining  (Fig.  3  E).  13 wk after induction the interstitial 
staining was even more intense (Fig. 3, F  and G  [higher 
magnification]). In  the areas  of fibrogenesis it is  signifi- 
cant, and a surprise for us to note, that tubular epithelium 
engulfed in the local inflammatory process have now be- 
gun expressing FSP1 (see discussion for further comments). 
The 5'Flanking Region of  FSP1 Has 
Fibroblast-Specific Promoter Activity 
To examine the promoter region of the FSP1 gene, we iso- 
lated a genomic clone from a NIH/3T3 genomic library us- 
ing a eDNA fragment from the 5' coding region (15). 1,800 
bp of the 5' flanking sequence was placed in front of a lu- 
ciferase reporter gene (Fig. 4 A  depicts the reporter con- 
struct) to study its activity in fibroblasts and nonfibroblasts 
relative  to  the  activity of the  SV40-promoter/enhancer. 
Fig. 4 B demonstrates that elements in the 5' flanking re- 
gion of FSP1  are strongly active in DFB  and 3T3 fibro- 
blasts, but not in nonfibroblast cells, such as proximal tu- 
bular cells (MCT), embryonic PYS-2 cells, nor mesangial 
cells (MMC). This pattern of activity is consistent with the 
Northern analysis showing the absence of FSP1 transcripts 
in these cells. 
Expression of  FSP1 in Epithelium Favors Conversion to 
a Fibroblast Morphology 
To investigate the possible phenotypic effects of FSP1 ex- 
pression, we performed two different experiments. In the 
first series of studies, we stably transfected MCT tubular 
epithelium with a  shuttle vector containing FSP1 eDNA 
driven by a CMV promoter (MCT.pFSP1.8) maintained in 
G418 (confirming Northern analysis not shown); control 
MCT  cells  were  stably  transfected  with  pcDNA.Neo 
(MC'r.pNeo). New expression of the FSP1 in MCT.pFSP1.8 
cells led to a change in morphology to a more stellate and 
elongated fibroblast phenotype  (Fig.  5  A)  compared to 
MCT.pNeo epithelial cells which were still capable of form- 
ing early epithelial sheets in subconfluent culture (Fig. 5 
B). Cells were also passaged onto gelatin-coated glass to 
stain for various cytoplasmic markers. MCT.pFSP1.8 cells 
stained positive for FSP1 by indirect immunofluorescence 
(Fig. 5 C) compared to MCT.pNeo which did not (Fig. 5 
D). MCT.pFSP1.8 cells also began expressing new vimen- 
tin (Fig. 5  E), and had reduced staining for cytokeratin 
(Fig. 5 G) when compared to controls (Fig. 5, F and H, re- 
spectively). 
In a second series of experiments, we cultured NP-1 tu- 
bular epithelium either submerged in a type I collagen gel 
or, as a  control, on the surface of type I  collagen-coated 
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dishes for 7 d (31). NP-1 tubular cells submerged in type 1 
collagen began  to  convert into mesenchymal fibroblasts 
and this was associated with the expression of new FSP1 
(Fig. 6 B) and vimentin (Fig. 6 D) when compared to con- 
trois (Fig. 6, A and C, respectively). Submerged NP-1 cells 
also express much less cytokeratin (Fig. 6 F), particularly 
as mesenchymalized cells start to detach and move away 
(dark center) compared to control NP-1  cells growing on 
the surface of the collagen gel (Fig. 6 E). 
Detection of  Fibroblasts in Developing l~ssues 
In situ hybridization of mouse embryos were probed with 
FSP1 cDNA at days E8.5, E12.5, and E13.5 to investigate 
the expression of FSP1 in developing tissues. The results 
are shown in Fig. 7 (plates E8.5, E12.5, and E13.5). FSP1 is 
not expressed in the embryo at day E8.5. Its message could 
be detected, however, in the decidual tissues (plate E8.5; 
panels A  and B). Decidual cells are derived from uterine 
fibroblasts and retain many fibroblast features including 
the ability to synthesize collagen (1, 22).  Spongotropho- 
blasts, certain areas of the yolk sac and perivascular cells 
of  the  umbilical  vessels  (plate  E8.5;  panels  C-E)  also 
stained positive. At day E12.5, FSP1 message can be de- 
tected  in the  embryonic dental mesenchyme, the  lepto- 
meningeal membrane,  around  the  sclerotomes, the  ura- 
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chus and in the periderm covering the caudal aspect of the 
embryo (Fig. 7; plate E12.5; panels A-E). At day E13.5, 
the following regions stain positively for FSPI: again the 
periodontal mesenchyme (Fig. 7; plate E13.5; panel B) and 
the myotomes (Fig. 7; plate E13.5; panel C). The vast ma- 
jority of kidney cells at that stage do not express FSP1, 
however strong expression can be detected in the support- 
ing capsules of the kidney and adrenal gland (Fig. 7; plate 
E13.5; panel E) as well as the thymus (Fig. 7; plate E13.5; 
panel D), which at that time is particularly rich in fibro- 
blasts  (64). Interestingly, intravascular cells in two blood 
vessels near the thymus and in the brain also stain positive, 
Strutz et al. Expression of FSPI in Fibroblasts  401 Figure 7.  FSP1 expression in mouse embryos by in situ hybridization of sagittal  sections.  (E8.5) A  (d marks the decidua) and B (shows 
the area e in A at a higher magnification; d again marks the decidua, e, embryo), the placenta C (v, placental vein, It, labyrinth tropho- 
blast, st, spongiotrophoblast), the yolk sac D, and the umbilical cord E (v, umbilical vein). Bright-field and corresponding dark-field mi- 
crographs. The embryo itself showed no detectable staining at day 8.5. (E12.5) FSP1 expression in organs and tissues of 12.5 d embryos. 
Sagittal  sections of the periodontal mesenchyme A  (drn, dental mesenchyme, p, pharynx), the leptomeningeal membrane B (hb,  hind- 
brain), the scleratomes C, the urogenital sinus D  (v, umbilical vein) and the caudal part of the skin E. Bright-field and corresponding 
dark-field micrographs. (E13.5) (A) Sagittal  sections of a cerebral vein (v); (B) the pharyngeal (p) area with periodontal mesenchyme 
(m); (C) the myotomes and prevertebrae (pv); (D) area around the thymus (t) with adjacent vein (v) at higher magnification; and (E) 
the kidney and adrenal gland (a). 
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(Fig. 7; plate E13.5; panels A and D). 
Discussion 
Microscopy studies have long created the impression that 
fibroblasts are a monotonous phenotype of limited com- 
plexity (27).  Fibroblasts  first appear  phylogenetically in 
lower chordates that form a mesoderm during gastrulation 
(38).  This mesodermal plane between the ectoderm and 
endoderm contains mesenchymal cells, and at some point, 
fibroblasts  that  create  necessary  fibrillar  infrastructure 
forming loose tissue spaces for cell migration during orga- 
nogenesis (36).  It is quite likely, however, that fibroblasts 
also function as part of the integrated biology of mature 
organisms. Several studies, in fact, now suggest that mor- 
phogenic  cues  from  tissue  microenvironments confer  a 
functional heterogeneity to fibroblasts harvested for cul- 
ture  (5,  44).  Although several  fibroblast  markers  have 
been described in the literature (4,  16,  18, 48),  none of 
them have proven to be highly specific. 
We initially approached the issue of determining fibro- 
blast  phenotype using a  conventional antibody strategy 
that was not successful. This then led to the notion of mak- 
ing transcript comparisons (30, 41, 68, 69) between fibro- 
blasts (TFB cells) harvested from the same microenviron- 
ment as  differentiated isogenic epithelium (MCT cells). 
After differential and subtractive  cloning, we were sur- 
prised to observe that fibroblasts produce very few unique 
transcripts compared to epithelium. Two transcripts en- 
coded intracellular proteins (FSP1 and $44al), and three 
encoded secretory proteins (al and ~2 collagen type I and 
osteopontin); none of them had extracellular domains as 
membrane-bound species. 
The detection of the two collagen chains was to be ex- 
pected, since abundant production of interstitial collagen 
type I is typical of fibroblasts (27),  although not specific 
(34). The interstitial collagens consist mainly of types I and 
III (61).  Other collagen chains were not detected possibly 
due to their low rate of transcription in fibroblasts in vitro 
(49) or their shared expression with epithelium (15).  Os- 
teopontin is a cell-matrix adhesion molecule (70) found in 
osteoblasts, macrophages, decidual cells, vascular smooth 
muscle cells, and distal tubular cells in the kidney, in addi- 
tion to fibroblasts (14, 51, 68). By Northern analysis, $44al 
was  also  expressed  in  several  different cell  types,  and 
showed low specificity for fibroblasts. The usefulness of 
osteopontin and $44al as fibroblast-specific markers seems 
unlikely. 
The cDNA sequence encoding FSP1 shares identity to 
clones of unknown function already in the database. Previ- 
ous isolated transcripts 18A2 (placental calcium-binding 
protein)  (42), pEL98 (30),  and rots1 (20)  were found in 
mice using differential hybridization. 18A2 was obtained 
by differential hybridization of serum stimulated vs un- 
stimulated Balb/c 3T3 fibroblasts (42, 50). Although 18A2 
was thought to represent a cell cycle--dependent transcript, 
the same group was unable to confirm their findings in a 
different line of embryonic fibroblasts or in primary cul- 
tures  of embryonic fibroblasts  (42).  The  term placental 
calcium-binding protein for 18A2 is probably due to its ex- 
pression in  decidual cells and  spongotrophoblasts,  both 
specialized fibroblasts (1, 22), as we observed on day E8.5 
in confirmation using in situ hybridization,  pEL98 was also 
obtained by the differential hybridization of Balb/c3T3 fi- 
broblasts against embryonic fibroblasts (30).  While there 
was a notable difference in expression, embryonic fibro- 
blasts clearly express the transcript encoding FSP1. Thus, 
these studies confirm our notion of fibroblast specificity 
for FSP1. 
The  fact that both  of our  cloning strategies  together 
yielded only five differentially expressed genes was a sur- 
prise. There are several possible explanations: First, the 
cloning methods we used were not sensitive enough, and 
perhaps a form of differential display would have identi- 
fied rarer transcripts than subtractive hybridization. Sec- 
ond, undifferentiated metanephric progenitor cells and re- 
nal fibroblasts harvested from mature tissues share similar 
properties  (21)(68,  69),  and consequently, the molecular 
difference between these mesenchymal cells and renal epi- 
thelium may lie in the added diversity of additional tran- 
scripts in the more specialized cell type. 
Our culture experiments, using epithelium transfected 
with FSP1  eDNA  or  epithelium submerged in  collagen 
type I, suggest that FSP1 is associated with, or may influ- 
ence the morphogenic conversion of fibroblasts. Immuno- 
fluorescent stainings indicate that new expression of FSP1 
is associated with a loss of cytokeratin and a gain of vimen- 
tin. Two groups have recently reported the interaction of 
FSPl-like proteins with tubulin (46)  and actin filaments 
(75),  and a  third group has described a  correlation with 
cell motility (74). Although more work is needed, this sug- 
gests that FSP1 in the cytoplasm may alter internal mor- 
phogenic cues that regulate the synthesis or assembly of 
other cytoskeletal proteins. In this regard, it has also been 
observed that other members of the S-100 protein family 
interact with components of the cytoskeleton (17). For ex- 
ample,  S-100b  protein  itself interacts with the  microtu- 
bule-associated "r protein inhibiting microtubule polymer- 
ization (8). Calpactin, another member of the family, acts 
as a  modulator of membrane-cytoskeletal interaction by 
inhibiting  tyrosine  kinase-dependent  phosphorylation 
(33).  Such Ca÷+-binding protein  interactions with cyto- 
skeletal filaments, as a hypothesis, may alter the morphol- 
ogy and migratory capacity of some differentiated cells. 
Furthermore,  the  transition  of epithelium into  onco- 
genic cells is sometimes associated with the acquisition of 
mesenchymal properties (26, 37). For example, breast can- 
cer cells can express either epithelial or fibroblastic pheno- 
types, as reflected by their morphologies and expression of 
intermediate filament proteins (71, 72). These fibroblastic 
tumor cells, which express vimentin, have a higher poten- 
tial to metastasize. Overexpression of vimentin in an epi- 
thelial breast cancer cell line, however, failed to induce the 
fibroblastic phenotype (71). It, therefore, is not surprising 
that FSP1, like other proteins of the S-100 family, are up- 
regulated in some tumor cells, especially in those with high 
metastatic potential (17, 20). The use of the FSP1 marker 
to study fibroblasts at the site of tumor metastases will 
have to be interpreted cautiously. 
Finally, our original impetus to find a generally reliable 
fibroblast marker was to facilitate the study of fibrogenesis 
following tissue injury. While we are just starting to ex- 
plore this issue in detail, we were struck by two observa- 
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further comment. First, fibroblasts have been traditionally 
thought to habitate the interstitial spaces of normal organ 
tissue awaiting a reparative assignment. Our evidence, us- 
ing FSP1  as a marker,  suggests however,  that fibroblasts 
are  not an  abundant phenotype in normal  organ  tissue. 
FSPl-positive  fibroblasts  are dispersed  sparsely through- 
out organs. This is consistent with the observation that col- 
lagens found in the infrastructure of parenchymal tissues 
delicately  lace  the  interstitial  spaces  in  limited  quantity 
(29, 77). Second, studies on the time course of interstitial 
fibrosis in injured organs demonstrate  the initial deposi- 
tion of collagen types I and III typically in close proximity 
to blood vessels (43, 52, 77), and as we observed, adjacent 
to occasional FSPl-positive fibroblasts in some perivascu- 
lar  spaces.  Fibrogenesis,  when  it  becomes  fully  active, 
however,  occurs  diffusely  in many regions  remote  from 
large  blood  vessels.  This  spreading  effect  has  been  ex- 
plained using in vitro observations supporting the notion 
that fibroblasts might migrate into areas of inflammatory 
injury by chemotaxis or haptotaxis and divide (2). 
Alternatively,  we  suggest  as a  new hypothesis, that fi- 
broblasts may at least be partly created at the site of injury 
by the conversion of parenchymal epithelium. In the cur- 
rent study we observed the new expression of FSP1 in typ- 
ically negative tubular epithelium at the site of interstitial 
inflammation, the new expression of FSP1 in tubular epi- 
thelium undergoing a transition to fibroblasts in collagen 
gels, and the development of a fibroblast phenotype in tu- 
bular epithelium after the overexpression of FSP1. Epithe- 
lial-mesenchymal  transitions  are  both  economical  and 
probable  as  operational  processes  in  the  early  develop- 
ment of complex organisms (32, 37). In hepatic fibrogene- 
sis, for example, the transition of lipocytes into myofibro- 
blasts is thought to be a key feature in the perpetuation of 
the disease  (7, 25). While these transitions could be con- 
sidered as a form of cell activation, and FSP1 as an activa- 
tion antigen, we believe phenotypic conversion is a more 
appropriate concept. Invoking an epithelial-mesenchymal 
transition for the origin of fibroblasts also provides an ex- 
planation for epithelial  atrophy in areas  of fibrogenesis, 
and the observed functional heterogeneity among cultured 
fibroblasts  harvested  from  different  microenvironments 
(5, 12). That is, fibroblasts that have transitioned from spe- 
cialized  epithelium  might  still  harbor  selected  receptors 
and  interactional  programs  that  modulate  according  to 
this imprinted background. 
FSP1 in mice  appears to be a reliable marker for map- 
ping the cell fate  of fibroblasts  among the mesenchymal 
anlagen. Transitions between normal cells are unexpected 
after organ development, and their presence in mature tis- 
sues reminds us of the conceptual links between the biol- 
ogy of development, repair, and oncogenesis. 
Dr. Okada was a recipient of a fellowship  from Eli Lilly Japan, Ltd. We 
also thank Dr. Peter Heeger (Cleveland Clinic, Cleveland,  OH) for pro- 
viding parts of the tissue sections from mice with interstitial nephritis. 
This work was supported in part by grants AR-46282, DK-07006, DK- 
30280, DK-41110,  and DK-45191  from the National  Institutes of Health 
and National Science Foundation grant DCB-06886 (C. W. Lo). Dr. Strutz 
was  supported  by  a  grant  from  the  Deutsche  Forschungsgemeinschaft 
(DFG: Str 388/1-1). 
Received for publication 7 July 1994 and in revised form 31 March 1995. 
References 
1. Abrahamsohn, P. A., and T. M. Zorn. 1993. Implantation and deeidualiza- 
tion in rodents. J. Exp. ZooL 266:603-628. 
2. Agelll,  M., and S. M. Wahl. 1986. Cytokines and fibrosis.  Clin. Exp. Rheu- 
matoL 4:379-388. 
3. Albert, S. E., F. Strutz, K. Shelton, T. Haverty, M. J. Sun, S. Li, A. Den- 
ham, R. A. Maki, and E. G. Neilson. 1994. Characterization of a cis-act- 
ing regulatory element which silences expression of the class II-A 13 gene 
in epithelium. J. Exp. Med. 180:233-240. 
4. Alpers, C. E., R. A. Seifert, K. L. Hudkins, R. J. Johnson, and D. F. Bo- 
wen-Pope. 1993. PDGF-receptor localizes  to mesangial, parietal epithe- 
lial,  and interstitial cells in human and primate kidneys. Kidney Int.  43: 
286--294. 
5. Alvarez, R. J., M. J. Sun, T. P. Haverty, R. V. Iozzo, J. C. Meyers, and E. G. 
Neilson.  1992. Biosynthetic and proliferative  characteristics of tubulo- 
interstitial fibroblasts probed with paracrine cytokines. Kidney Int.  41: 
14-23. 
6. Anderson, D. J., and R. Axel. 1985. Molecular probes for the development 
and plasticity of neural crest derivatives. Cell, 42:649-662. 
7. Bachem, M. G., D. Meyer, R. Melchior, K. M. Sell, and A. M. Gressner. 
1992.  Activation  of rat  liver perisinusoidal  lipocytes  by transforming 
growth factors derived from myofibroblast-like cells--a potential mecha- 
nism of self perpetuation in liver fibrogenesis. J. Clin. Invest.  89:19-27. 
8. Baudier, J., and R. D. Cole. 1988. Interaction between microtubule associ- 
ated proteins and S-100b  regulate phosphorylation by Ca2÷/calmodulin 
dependant protein kinase II. J. Biol.  Chem.  263:5876-5883. 
9. Bernfield, M. 1989. Extracellular matrix. Curr. Opin.  Cell Biol. 1:953-955. 
10. Bornstein, P., and H. Sage. 1989. Regulation of collagen expression. Progr. 
Nucl. Acid. Res.  & Mol.  Biol. 37:67-106. 
11. Bradley, A., M. Evans, M. H. Kaufman, and E. Robertson. 1984. Forma- 
tion of germ-line chimeras from embryo-derived teratocarcinoma cell 
lines. Nature (Lond. ). 309:255-256. 
12. Breen, E., V. M. Falco, M. Absher, and K. R. Cutroneo. 1990. Subpopula- 
tions of rat lung fibroblasts with different amounts of type I and type III 
collagen mRNAs. Z Biol.  Chem. 265:6286--6289. 
13. Broekelman, T. J., A, H. Limper, T, V. Colby, and J. A. McDonald. 1991. 
Transforming growth factor 131 is present at sites of extracellular matrix 
gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA. 
88:6642-6646. 
14. Butler, W. T. 1989. The nature and signifcance of osteopontin. Connect. 
Tissue Res. 23:123-136. 
15. Danoff, T. M., P. A. Lalley, Y. S. Chang, P. S. Heeger, and E. G. Neilson. 
1994. Cloning, genomic organization, and chromosomal localization  of 
the Scya5 gene encoding the murine chemokine RANTES. J. Immunol. 
152:1182-1189. 
16. Darby, I., O. Skalli, and G. Gabbiani. 1990. u-Smooth muscle actin is tran- 
siently expressed by myofibroblasts during experimental wound healing. 
Lab. Invest.  63:21-30. 
17. Davies, B. R., M. P. A. Davies, F. E. M. Gibbs, R. Barraclough, and P. S. 
Rudland. 1993. Induction of the metastatic phenotype by transfection of 
a benign rat mammary epithelial cell line with the gene for p9Ka, a rat 
calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene. 
8:999-1008. 
18. Dawson, T.  P.,  R.  Gandhi,  M.  L. Hir,  and  B.  Kaissling.  1989. Ecto-5'- 
nucleotidase: localization in rat kidney by light microscopic histochemical 
methods. J. Histochem. Cytochem.  37:39-47. 
19. Dony, C., and P. Gruss. 1987. Specific expression of the Hox-5 complex ho- 
meobox-containing genes during limb development. EMBO (Eur.  Mol. 
Biol.  Organ.) J. 6:2965-2975. 
20. Ebralidze, A., E. Tulchinsky, M.  Grigorian, A. Afanasyeva, V. Senin, E. 
Revazova, and E. Lukanidin.  1989. Isolation and characterization  of a 
gene specifically  expressed in different metastatic cells  and whose de- 
duced gene product has a high homology to a CaZ+-binding protein fam- 
ily. Genes Dev. 3:1086-1093. 
21. Ekblom, P., E. Lehtonen, L. Saxen, and R. Timpl. 1981. Shift in collagen 
type as an early response to induction of the metanephric mesenchyme. J. 
Cell Biol.  89:276-283. 
22. Enders, A. C. 1991. Current topic:  structural responses of the primate en- 
dometrium to implantation. Placenta.  12:309-325. 
23. French, B. T., W. Lee, and G. G. Maul.  1985. Nucleotide  sequence of a 
cDNA clone for mouse proal(I) collagen protein. Gene(Amst.). 39:311- 
312. 
24. Friedman, S. L. 1993. The cellular basis of hepatic fibrosis. N. EngL J. Med. 
328:1828-1835. 
25. Friedmann, S. L., and M. J. P. Arthur. 1989. Activation of cultured rat he- 
patic lipocytes by Kupffer cell conditioned medium. Direct enhancement 
of matrix synthesis and stimulation of cell proliferation via induction of 
platelet-derived growth factor receptors. J. Clin. Invest.  84:1780-1785. 
26. Frixen, U. H., J. Behrens, M.  Sachs, G. Eberle,  B.  Voss, A. Warda, D. 
Lochner, and W. Birchmeier. 1991. E-Cadherin-mediated cell-cell adhe- 
sion prevents invasiveness of human carcinoma cells. J.  Cell Biol.  113: 
173-185. 
27. Gabbiani, G., and E. Rungger-Br~indle.  1981. The fibroblast. In Handbook 
of Inflammation. Tissue Repair and Regeneration. Vol. 3. L  Glynn, edi- 
tor. Elsevier/North Holland Biomedical Press, Amsterdam. pp. 1-50. 
The Journal of Cell Biology, Volume 130, 1995  404 28.  Gilligan, A.,  L. Jewett,  D.  Simon, I. Damjanov,  F. M. Matschinsky, H. 
Weik, C. Pinkert,  and B. B. Knowles. 1989. Functional pancreatic beta- 
cell line from SV40 T-antigen transgenic mouse. Diabetes. 38:1056-1062. 
29.  Goldberg, H., T. Helaakoski, L. A. Garrett,  G. Karsenty, A. Pellegrino, G. 
Lozano, S. Malty, and B. deCrombrugghe.  1992. Tissue-specific expres- 
sion of the mouse alpha-2(I)  collagen promoter--studies in transgenic 
mice and in tissue-culture cells. J. Biol. Chem. 267:19622-19630. 
30. Goto, K., H. Endo,  and T. Fujiyoshi. 1988. Cloning of the sequences ex- 
pressed  abundantly  in established  cell lines: identification  of a cDNA 
clone highly homologous to S-100, a calcium binding protein. J. Biochem. 
103:48-53. 
31.  Greenburg,  G., and E. D. Hay. 1982. Epithelia  suspended in collagen gels 
can lose polarity  and express characteristics of migrating mesenchymal 
cells. J. Cell BioL 95:333-339. 
32. Greenburg, G., and E. D. Hay. 1986. Cytodifferentiation  and tissue pheno- 
type change during transformation  of embryonic lens epithelium to mes- 
enchyme-like cells. Dev. Biol. 115:363-379. 
33. Hagiwara,  M., M.  Ochiai, K. Owada,  T. Tanaka,  and  H. Hidaka.  1988. 
Modulation  of tyrosine phosphorylation  of p36 and other substrates  by 
the $100 protein. J. Biol. Chem. 263:6438-6441. 
34. Haverty, T. P., C. J. Kelly, W. H. Hines, P. S. Amenta, M. Watanabe, R. A. 
Harper, N. A. Kefalides, and E. G. Neilson. 1988. Characterization  of a 
renal tubular epithelial cell line which secretes the autologous target anti- 
gen of autoimmune  experimental  interstitial  nephritis. J.  Cell Biol.  107: 
135%1367. 
35. Haverty, T. P., C. J. Kelly, J. R. Hoyer, R. Alvarez, and E. G. Neilson. 1992. 
Tubular antigen-binding  proteins  repress  transcription  of type  IV col- 
lagen in the autoimmune  target  epithelium  of experimental  interstitial 
nephritis. J. Clin. Invest. 89:517-523. 
36. Hay, E. D. 1968. Organization and fine structure of epithelium and mesen- 
chyme in the developing chick embryo. In Epithelial-Mesenchymal Inter- 
actions. R. E. B. R. Fleischmajer,  editor.  Williams and  Wilkins, Balti- 
more, MD. pp. 31-55. 
37. Hay, E.  D.  1990. Epithelial-mesenchymal  transitions.  Sere.  Dev.  Biol.  1: 
347-356. 
38. Hay, E. D. 1991. Collagen and other matrix glycoproteins in embryogene- 
sis. In Cell Biology of Extracellular  Matrix. E. D. Hay, editor. Plenum 
Press, NY. 419-462. 
39. Hsu, S. M., L. Raine, and H. Fanger. 1981. The use of avidin-biotin-peroxi- 
dase (ABC) complex in immunoperoxidase techniques: a comparison be- 
tween  ABC and  unlabeled  antibody  (PAP)  procedures.  Z  Histoehem. 
Cytochem. 29:577-580. 
40. Iozzo, R. V. 1985. Proteoglycans, structure, function, and role in neoplasia. 
Lab. Invest. 53:373-396. 
41. Iwai, N., and T. Inagami. 1991. Isolation of preferentially  expressed genes 
in the kidneys of hypertensive rats. Hypertension. 17:161-169. 
42. Jackson-Grusby,  L. L., J. Swiergiel, and D. I. H. Linzer. 1987. A growth- 
related mRNA in cultured mouse cells encodes a placental calcium bind- 
ing protein. Nucleic Acids Res. 15:6677~6690. 
43. K/ih/iri, V.-M., M.  Sandberg,  H. Kalimo, T. Vuori,  and  E.  Vuori.  1988. 
Identification  of fibroblasts  responsible  for increased  collagen produc- 
tion in localized scleroderma by in situ hybridization. J. Invest. Dermatol. 
90:664--670. 
44. Komuro, J.  1990. Re-evaluation  of fibroblasts  and  fibroblast-like  cells. 
Anat. Embryol. 182:103-112. 
45. Kuncio, G. S., E. G. Neilson, and T. Haverty.  1991. Mechanisms of tubu- 
lointerstitial fibrosis. Kidney Int. 39:550-556. 
46. Lakshmi, M. S., C. Parker,  and G. V. Sherbet. 1993. Metastasis associated 
mtsI and nm23 genes affect tubulin polymerisation in B16 melanomas: a 
possible  mechanism  of their  regulation  of metastatic  behavior  of tu- 
mours. Anticancer Res. 13:299-304. 
47. Lamb, B. T., K. Satyamoorthy,  D. Solter, A. Basu, M. Q. Xu, R. Wein- 
mann, and C. C. Howe. 1992. A DNA element that regulates expression 
of an endogenous retrovirus during F9 cell differentiation is E1A depen- 
dent. Mol. Cell. Biol. 12:4824--4833. 
48. LeHir, M., and B. Kaissling. 1989. Distribution of 5'-nucleotidase in the re- 
nal interstitium of the rat. Cell Tissue Res. 258:177-182. 
49. Liau, G., Y. Yamada, and B. deCrombrugghe. 1985. Coordinate  regulation 
of the levels of type III and type I collagen mRNA in most but not all 
mouse fibroblasts. J. Biol. Chem. 260:531-536. 
50.  Linzer, D. I. H., and D. Nathans. 1983. Growth-related  changes in specific 
mRNAs of cultured  mouse cells. Proc. Natl. Acad.  Sci.  USA.  80:4271- 
4275. 
51.  Lopez, C. A., J. R. Hoyer, P. D. Wilson, P. Waterhouse,  and D. T. Den- 
hardt. 1993. Heterogeneity  of osteopontin expression among nephrons in 
mouse kidneys and enhanced expression in sclerotic glomeruli. Lab. In. 
vest. 69:355-363. 
52. Maher, J. J., and R. F. McGuire. 1990. Extracellular matrix gene expression 
increases preferentially  in rat lipocytes and sinusoidal endothelial  cells 
during hepatic fibrosis in vivo. J. Clin. Invest. 86:1641-1648. 
53. Mann, R., C. J. Kelly, W. H. Hines, M. D. Clayman, N. Blanchard,  M. J. 
Sun, and E. G. Neilson. 1987. Effector  T cell differentiation  in experi- 
mental interstitial nephritis. I. The development and modulation of effec- 
tor lymphocyte maturation  by I-J+ regulatory T cells. J. Immunol.  136: 
4200-4208. 
54. Merritt,  S., P. Killen, S. Phan, and R. C. Wiggins. 1990. Analysis of cd(I) 
procollagen, M(IV) collagen and 13-actin mRNA in glomeruli and cortex 
of rabbits with experimental  anti-GBM disease: evidence of early extra- 
glomerular collagen biosynthesis. Lab. Invest. 63:762-769. 
55. Miyazaki, Y., M.  Setoguchi, S. Yoshida, Y. Higuchi, S. Akizuki,  and  S. 
Yamamoto. 1990. The mouse osteopontin gene. Expression in monocytic 
lineages and  complete  nucleotide  sequence. J.  Biol.  Chem.  265:14432- 
14438. 
56. Nagai,  K.,  and  H.  C.  Thorgersen.  1984. Generation  of 13-globin by  se- 
quence-specific proteolysis of a hybrid protein  produced  in Escherichia 
coll. Nature (Lond.). 309:810812. 
57. Nakatsukasa,  H., P. Nagy, R. P. Evarts, C. C. Hsia, E. Marsden, and S. S. 
Thorgeirsson.  1990. Cellular distribution  of transforming factor-13 1 and 
procollagen  types  I,  III, and  IV  transcripts  in  carbon tetrachloride- 
induced rat liver fibrosis. J. Clin. Invest. 85:1833.1843. 
58. Neilson, E. G., R. Kalluri, M. J. Sun, S. Gunwar, T. Danoff, M. Mariyama, 
J. C. Meyers, S. T. Reeders, and B. G. Hudson. 1993. Specificity of Good- 
pasture  autoantibodies  for the recombinant  noncollagenous domains of 
human type IV collagen. J. Biol. Chem. 268:8402~405. 
59. Nordeen,  S. K. 1988. Luciferase reporter gene vectors for analysis of pro- 
moters and enhancers. Biotechniques.  6:454-457. 
60.  Obeso, J., J. Weber,  and  R. Auerbach.  1990. A hemangioendothelioma- 
derived cell line: its use as a model for the study of endothelial cell biol- 
ogy. Lab. Invest. 63:259-269. 
61. Parry, D. A. D. 1988. The molecular and fibrillar structure of collagen and 
its relationship  to the  mechanical properties  of connective tissue. Bio- 
phys. Chem. 29:195-209. 
62. Phillips, C. L., L. W. Lever, S. R. Pinnell, L. D. Quarles,  and R. J. Wen- 
strup. 1991. Construction of a full-length murine proa2(I) collagen eDNA 
by the polymerase chain reaction. J. Invest. Dermatol. 97:980-984. 
63. Rosenthal,  N. 1987. Identification  of regulatory elements of cloned genes 
with functional analysis. Methods Enzymol. 152:704-720. 
64. Rugh, R. 1990. The Mouse. Its Reproduction  and Development.  Oxford 
University Press, Oxford, New York, Tokyo. 
65. Sappino, A. P., W. Schurch, and G. Gabbiani. 1990. Biology of disease. Dif- 
ferentiation  repertoire  of fibroblastic  cells: expression  of cytoskeletal 
proteins as marker of phenotypic modulations. Lab. Invest. 63:144-161. 
66. Schneppenheim,  R., U. Budde,  N. Dahlmann,  and  P.  Rautenberg.  1991. 
Luminography--a new, highly sensitive visualization method for electro- 
phoresis. Electrophoresis. 12:367-372. 
67. Schwartz, A. L., S. E. Fridovich, B. B. Knowles, and H. F. Lodish. 1981. 
Characterization of the asialoglycoprotein receptor in a continuous hepa- 
toma line. J. Biol. Chem. 256:8878-8881. 
68. Shanahan,  C. M., P. L. Weissberg, and J. C. Metcalfe.  1993. Isolation  of 
gene markers of differentiated  and proliferating vascular smooth muscle 
cells. Circulation Res. 73:193-204. 
69. Sive, H. L., and T. St John. 1988. A simple subtractive hybridization tech- 
nique employing photoactivatable  biotin and phenol extraction. Nucleic 
Acid Res. 16:10937. 
70. Somerman, M. J., C. W. Prince, J. J. Sauk, R. A. Foster, and W. T. Butler. 
1987. Mechanism of fibroblast attachment  to bone extracellular  matrix: 
role of a 44 kilodalton  bone phosphoprotein.  J.  Bone Min.  Res.  2:25% 
265. 
71. Sommers, C. L., S. E. Heckford,  J. M. Skerker, P. Worland, J. A. Torri, 
E. W. Thompson, S. W. Byers, and E. P. Gelmann. 1992. Loss of epithe- 
lial markers and acquisition of vimentin expression in adriamycin- and 
vinblastine-resistant human breast cancer cell lines. Cancer Res. 52:5190- 
5197. 
72. Sommers, C. L., D. Walker-Jones, S. E. Heckford, P. Worland, E. Valver- 
ins, R. Clark, M. Stampfer, and E. P. Gelmann.  1989. Vimentin rather 
than keratin expression in some hormone-independant  breast cancer cell 
lines and in oncogene-transformed  mammary epithelial cells. Cancer Res. 
49:4258-4263. 
73.  Strickland, S., K. K. Smith, and K. R. Marotti. 1980. Hormonal induction of 
differentiation in teratocarcinoma  stem cells: generation of parietal endo- 
derm by retinoic acid and dibutyryl cAMP. Cell. 21:347-355. 
74. Takenaga, K., Y. Nakamura, H. Endo, and S. Sakiyama. 1994. Involvement 
of S100-related calcium binding protein pEL98 in cell motility and tumor 
cell invasion. Jpn. J. Cancer Res. 85:831-839. 
75. Watanabe,  Y., N. Usada, H. Minami, T. Morita, S. Tsugane, R. lshikawa, 
K. Kohama, Y. Tomida, and H. Hidaka. 1993. Calvasculin, as a factor af- 
fecting the microfilament assemblies in rat fibroblasts transfected  by src 
gene. FEBS (Fed.  Eur. Biochem. Soc.) Lett. 324:51-55. 
76. Weber, K. T. 1989. Cardiac interstitium in health and disease: the fibrillar 
collagen network. J. Am. Coll. Cardiol. 13:1637-1652. 
77. Wiggins, R., M. Goyal, S. Merritt, and P. D. Killen. 1993. Vascular adventi- 
tial cell expression of collagen I messenger ribonucleic acid in anti-glom- 
erular basement membrane antibody-induced  crescentic nephritis in the 
rabbit. Lab. Invest. 68:557-565. 
78. Wolf, G., U. Haberstroh,  and E. G. Neilson. 1992. Angiotensin  II stimu- 
lates the proliferation and biosynthesis of type I collagen in cultured mu- 
rine mesangial cells. Am. J. Pathol. 140:95-107. 
Strutz et al. Expression of FSP1 in Fibroblasts  405 